BriefCam Ltd., a developer and provider of Video Synopsis systems for reviewing, analyzing and indexing of surveillance camera content, was recently awarded the IFSEC Security Industry Award 2010. BriefCam won against five other contenders in the category of "CCTV System Product of the Year".
Video Synopsis is BriefCam's major innovation, a proprietary image-processing technology that creates synopses of original full-length surveillance videos. BriefCam provides a complete representation of all events occurring during hours of video footage in a condensed clip as short as a few minutes in length.
The synopsis is made possible by simultaneously presenting multiple objects and activities that have occurred at different times. Video Synopsis enables the rapid review and indexing of captured video footage -- with an index to the original source video; live video feed online and archival video footage offline -- for on-the-spot event tracking, forensic investigation and evidence discovery.
The company has 161 employees, after firing 6% of its workforce last year. The company is targeting markets worth an estimated tens of billions of dollars. Most sales in 2009 were in Europe, where two companies, GE Healthcare and Rossylin Medical Ltd., account for over 20% of Insightec's sales. GE Healthcare also owns 16.9% of Insightec. The company's orders backlog totaled $12.7 million at the end of March 2010.
Elbit Imaging invested $14.2 million in Gamida Cell through the end of 2009, compared with its investment of $89.3 million in Insightec. Gamida Cell's other investors include Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA), with a 7.5% holding, and Clal Biotechnology Industries Ltd. (TASE: CBI), with a 16.8% stake, which it acquired through its in April of Biomedical Investments (1997) Ltd. a month ago, and Israel Healthcare Ventures Ltd., with 16.3%.